ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone214-905-5145
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$720,000.00
Profitability
Miscellaneous
Employees2
Next Earnings DateN/A
OptionableNot Optionable
Uluru (OTCMKTS:ULUR) Frequently Asked Questions
What is Uluru's stock symbol?
Uluru trades on the OTCMKTS under the ticker symbol "ULUR."
Has Uluru been receiving favorable news coverage?
Media stories about ULUR stock have been trending negative recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Uluru earned a daily sentiment score of -2.2 on InfoTrie's scale. They also assigned news stories about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Uluru.
Who are some of Uluru's key competitors?
Some companies that are related to Uluru include Innovate Biopharmaceuticals (INNT), China SXT Pharmaceuticals (SXTC), Sophiris Bio (SPHS), Guardion Health Sciences (GHSI), Ceapro (CRPOF), OTCMKTS:EMBI (EMBI), Aileron Therapeutics (ALRN), Adial Pharmaceuticals (ADIL), OncoSec Medical (ONCS), AEterna Zentaris (AEZS), Bio-Path (BPTH), Teligent (TLGT), Nemus Bioscience (NMUS), ProPhase Labs (PRPH) and Advaxis (ADXS).
What other stocks do shareholders of Uluru own?
Who are Uluru's key executives?
Uluru's management team includes the folowing people:
- Ms. Vaidehi A. Shah, Chairman & CEO (Age 42)
- Mr. P. K Ramachandran, Chief Financial Officer (Age 65)
How do I buy shares of Uluru?
Shares of ULUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Uluru's stock price today?
One share of ULUR stock can currently be purchased for approximately $0.03.
How big of a company is Uluru?
What is Uluru's official website?
How can I contact Uluru?
Uluru's mailing address is 4410 BELTWAY DRIVE, ADDISON TX, 75001. The specialty pharmaceutical company can be reached via phone at 214-905-5145.
MarketBeat Community Rating for Uluru (OTCMKTS ULUR)
MarketBeat's community ratings are surveys of what our community members think about Uluru and other stocks. Vote "Outperform" if you believe ULUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
